RSVP and reserve your spot today for ARM's 5th Annual Regen Med & Advanced Therapies State of the Industry Briefing, an in-depth analysis by top analysts and executives on recent developments and the future outlook for the field over the coming year.

The result of this membership merger is the creation of one, global organization operating on behalf of the advanced therapies and regenerative medicine sector (cell therapy, gene therapy and tissue engineering) in both the U.S. and Europe.

Save the date - March 25, 2015 - for ARM's 3rd Annual Regen Med Investor Day! Don't miss the only financing event organized specifically for the advanced therapies sector providing institutional, strategic and venture investors with a unique opportunity to gain insight into the top regen med and advanced therapies companies.

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

200+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more